Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biagio De Angelis

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Cancer Research|April 5, 2018
Adoptive Immunotherapy Using PRAME-Specific T Cells in MedulloblastomaDomenico Orlando, Evelina Miele, Biagio De Angelis, et al.
Blood Advances|June 25, 2025
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapseFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Journal of Hematology & Oncology|November 6, 2022
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemiaSimona Caruso, Biagio De Angelis, Francesca Del Bufalo, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomasClaudia Manuela Arnone, Vinicia Assunta Polito, Angela Mastronuzzi, et al.
Blood|May 12, 2023
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALLFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Frontiers in Immunology|May 9, 2025
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoringBiagio De Angelis, Maria Luisa D'Amore, Pacôme Lecot, et al.
Frontiers in Oncology|May 16, 2022
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling SuppressionClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Cell Death Discovery|November 3, 2025
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcomaFrancesca Antonella Aiello, Lucrezia D'Archivio, Marika Attili, et al.
Nature Communications|June 9, 2023
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignanciesSimona Manni, Francesca Del Bufalo, Pietro Merli, et al.
Journal for Immunotherapy of Cancer|June 17, 2021
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blastsConcetta Quintarelli, Marika Guercio, Simona Manni, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Cancer Research|April 5, 2018
Adoptive Immunotherapy Using PRAME-Specific T Cells in MedulloblastomaDomenico Orlando, Evelina Miele, Biagio De Angelis, et al.
Blood Advances|June 25, 2025
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapseFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Journal of Hematology & Oncology|November 6, 2022
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemiaSimona Caruso, Biagio De Angelis, Francesca Del Bufalo, et al.
Journal for Immunotherapy of Cancer|May 8, 2021
Oncolytic adenovirus and gene therapy with EphA2-BiTE for the treatment of pediatric high-grade gliomasClaudia Manuela Arnone, Vinicia Assunta Polito, Angela Mastronuzzi, et al.
Blood|May 12, 2023
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALLFrancesca Del Bufalo, Marco Becilli, Chiara Rosignoli, et al.
Frontiers in Immunology|May 9, 2025
European survey on CAR T-Cell analytical methods from apheresis to post-infusion immunomonitoringBiagio De Angelis, Maria Luisa D'Amore, Pacôme Lecot, et al.
Frontiers in Oncology|May 16, 2022
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling SuppressionClara Perrone, Silvia Pomella, Matteo Cassandri, et al.
Cell Death Discovery|November 3, 2025
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3-FOXO1 rhabdomyosarcomaFrancesca Antonella Aiello, Lucrezia D'Archivio, Marika Attili, et al.
Nature Communications|June 9, 2023
Neutralizing IFNγ improves safety without compromising efficacy of CAR-T cell therapy in B-cell malignanciesSimona Manni, Francesca Del Bufalo, Pietro Merli, et al.
Journal for Immunotherapy of Cancer|June 17, 2021
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blastsConcetta Quintarelli, Marika Guercio, Simona Manni, et al.
Pageof 7